Resistance reported from China antimicrobial surveillance network (CHINET) in 2018

Clinical and Laboratory Standards Institute (CLSI) (2018) Performance standards for antimicrobial susceptibility testing. M100 28th edition. Wayne, PA

Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC et al (2018) 2017 surveillance of bacterial resistance in China. Chin J Infect Chemother 18(3):241–251

Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC et al (2016) Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect 22(Suppl 1):S9–S14

Qin X, Yang Y, Hu F, Zhu D (2014) Hospital clonal dissemination of Enterobacter aerogenes producing carbapenemase KPC-2 in a Chinese teaching hospital. J Med Microbiol 63(Pt 2):222–228

Zhu DM, Wang F, Hu FP, Jiang XF, Ni YX, Sun JY et al (2011) 2010 surveillance of bacterial resistance in China. Chin J Infect Chemother 11(5):321–329

Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC et al (2017) CHINET 2016 surveillance of bacterial resistance in China. Chin J Infect Chemother 17(5):481–491

Wang H, Yu YS, Wang MG, Ni YX, Ma Y, Ren JK et al (2013) Expert consensus on the procedure of tigecycline in vitro susceptibility test. Chin J Lab Med 26(7):584–587

Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y et al (2017) Nationwide surveillance of clinical Carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine. 19:98–106

Yin D, Dong D, Li K, Zhang L, Liang J, Yang Y et al (2017) Clonal dissemination of OXA-232 Carbapenemase-producing Klebsiella pneumoniae in neonates. Antimicrob Agents Chemother 61(8)